Hypoxia-Inducible Factor-2α Limits Natural Killer T Cell Cytotoxicity in Renal Ischemia/Reperfusion Injury

Journal of the American Society of Nephrology

Volumn 27, Issue 1, 2016, Pages 92-106

  Zhang, Jianjun ^a   Han, Conghui ^b   Dai, Huijuan ^a   Hou, Jianquan ^c   Dong, Yang ^b   Cui, Xiaolan ^a   Xu, Longmei ^a   Zhang, Ming ^a   Xia, Qiang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b XUZHOU CENTRAL HOSPITAL   (China)

^c THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A2A RECEPTOR; CREATININE; FAS LIGAND; HYPOXIA INDUCIBLE FACTOR 2ALPHA; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; ENDOTHELIAL PAS DOMAIN-CONTAINING PROTEIN 1;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE EXACERBATION; FLOW CYTOMETRY; HYPOXIA; IN VITRO STUDY; IN VIVO STUDY; KIDNEY ISCHEMIA; MALE; MONONUCLEAR CELL; MOUSE; NATURAL KILLER T CELL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEPLETION; PROTEIN EXPRESSION; REPERFUSION INJURY; SPLEEN CELL; THYMOCYTE; UPREGULATION; UREA NITROGEN BLOOD LEVEL; ANIMAL; IMMUNOLOGY; KIDNEY; LYMPHOCYTE ACTIVATION; PHYSIOLOGY; VASCULARIZATION;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; KIDNEY; LYMPHOCYTE ACTIVATION; MALE; MICE; NATURAL KILLER T-CELLS; RECEPTOR, ADENOSINE A2A; REPERFUSION INJURY;

EID: 84954427967     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2014121248     Document Type: Article

References (54)

1. Jang HR, Ko GJ, Wasowska BA, Rabb H: The interaction between ischemia-reperfusion and immune responses in the kidney. J MolMed (Berl) 87: 859-864, 2009
2. Thurman JM: Triggers of inflammation after renal ischemia/reperfusion. Clin Immunol 123: 7-13, 2007
3. Huang Y, Rabb H, Womer KL: Ischemia-reperfusion and immediate T cell responses. Cell Immunol 248: 4-11, 2007
4. Rabb H, Daniels F,O'DonnellM, HaqM, Saba SR, KeaneW, TangWW: Pathophysiological role of T lymphocytes in renal ischemia-reperfusion injury in mice. Am J Physiol Renal Physiol 279: F525-F531, 2000
5. BurneMJ,Daniels F, ElGhandour A,Mauiyyedi S, Colvin RB,O'Donnell MP, Rabb H: Identification of the CD4(+) T cell as a major pathogenic factor in ischemic acute renal failure. J Clin Invest 108: 1283-1290, 2001
6. Day YJ, Huang L, Ye H, Li L, Linden J, Okusa MD: Renal ischemiareperfusion injury and adenosine 2A receptor-mediated tissue protection: The role of CD4+ T cells and IFN-gamma. J Immunol 176: 3108-3114, 2006
7. Li L, Huang L, Sung SS, Lobo PI, Brown MG, Gregg RK, Engelhard VH, OkusaMD: NKT cell activationmediates neutrophil IFN-gamma production and renal ischemia-reperfusion injury. J Immunol 178: 5899-5911, 2007
8. Lappas CM, Day YJ, Marshall MA, Engelhard VH, Linden J: Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation. J ExpMed 203: 2639-2648, 2006
9. Ohta A, Diwanji R, Kini R, Subramanian M, Ohta A, Sitkovsky M: In vivo T cell activation in lymphoid tissues is inhibited in the oxygen-poor microenvironment. Front Immunol 2; 27: 1-10, 2011
10. McNamee EN, Korns JohnsonD, HomannD, Clambey ET: Hypoxia and hypoxia-inducible factors as regulators of T cell development, differentiation, and function. Immunol Res 55: 58-70, 2013
11. Biju MP, Neumann AK, Bensinger SJ, Johnson RS, Turka LA, Haase VH: Vhlh gene deletion induces Hif-1-mediated cell death in thymocytes. Mol Cell Biol 24: 9038-9047, 2004
12. Lukashev D, Klebanov B, Kojima H, Grinberg A, Ohta A, Berenfeld L, Wenger RH, Ohta A, Sitkovsky M: Cutting edge: Hypoxia-inducible factor 1alpha and its activation-inducible short isoform I.1 negatively regulate functions of CD4+ and CD8+ T lymphocytes. J Immunol 177: 4962-4965, 2006
13. Rankin EB, Biju MP, Liu Q, Unger TL, Rha J, Johnson RS, Simon MC, Keith B,Haase VH: Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo. J Clin Invest 117: 1068-1077, 2007
14. Rankin EB, Rha J, Selak MA, Unger TL, Keith B, Liu Q, Haase VH: Hypoxia-inducible factor 2 regulates hepatic lipidmetabolism.MolCell Biol 29: 4527-4538, 2009
15. Mastrogiannaki M, Matak P, Peyssonnaux C: The gut in iron homeostasis: Role of HIF-2 under normal and pathological conditions. Blood 122: 885-892, 2013
16. Rankin EB, Rha J, Unger TL,Wu CH, Shutt HP, Johnson RS, Simon MC, Keith B, Haase VH: Hypoxia-inducible factor-2 regulates vascular tumorigenesis in mice. Oncogene 27: 5354-5358, 2008
17. Imtiyaz HZ, Williams EP, Hickey MM, Patel SA, Durham AC, Yuan LJ, Hammond R, Gimotty PA, Keith B, SimonMC: Hypoxia-inducible factor 2alpha regulates macrophage function in mouse models of acute and tumor inflammation. J Clin Invest 120: 2699-2714, 2010
18. Zhang S,Han CH, Chen XS, Zhang M, Xu LM, Zhang JJ, Xia Q: Transient ureteral obstruction prevents against kidney ischemia/reperfusion injury via hypoxia-inducible factor (HIF)-2a activation. PLoS ONE 7: E29876, 2012
19. He K, Chen X,Han C, Xu L, Zhang J, Zhang M, XiaQ: Lipopolysaccharideinduced cross-tolerance against renal ischemia-reperfusion injury is mediated by hypoxia-inducible factor-2a-regulated nitric oxide production. Kidney Int 85: 276-288, 2014
20. Kapitsinou PP, Sano H, Michael M, Kobayashi H, Davidoff O, Bian A, Yao B, Zhang MZ, Harris RC, Duffy KJ, Erickson-Miller CL, Sutton TA, Haase VH: Endothelial HIF-2 mediates protection and recovery from ischemic kidney injury. J Clin Invest 124: 2396-2409, 2014
21. Kishimoto H, Ohteki T, Yajima N, Kawahara K, Natsui M, Kawarasaki S, Hamada K, Horie Y, Kubo Y, Arase S, Taniguchi M, Vanhaesebroeck B, Mak TW, Nakano T, Koyasu S, Sasaki T, Suzuki A: The Pten/PI3K pathway governs the homeostasis of Valpha14iNKT cells. Blood 109: 3316-3324, 2007
22. Wingender G, Krebs P, Beutler B, Kronenberg M: Antigen-specific cytotoxicity by invariant NKT cells in vivo is CD95/CD178-dependent and is correlated with antigenic potency. J Immunol 185: 2721-2729, 2010
23. KoGJ, JangHR,Huang Y,Womer KL, LiuM, Higbee E, Xiao Z, Yagita H, Racusen L, Hamad AR, Rabb H: Blocking Fas ligand on leukocytes attenuates kidney ischemia-reperfusion injury. J Am Soc Nephrol 22: 732-742, 2011
24. Nakajima H, Mizuta N, Fujiwara I, Sakaguchi K, Ogata H, Magae J, Yagita H, Koji T: Blockade of the Fas/Fas ligand interaction suppresses hepatocyte apoptosis in ischemia-reperfusion rat liver. Apoptosis 13: 1013-1021, 2008
25. Okusa MD, Linden J, Macdonald T, Huang L: Selective A2A adenosine receptor activation reduces ischemia-reperfusion injury in rat kidney. Am J Physiol 277: F404-F412, 1999
26. Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE: RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68: 869-877, 1992
27. Koshiba M, Kojima H, Huang S, Apasov S, Sitkovsky MV: Memory of extracellular adenosine A2A purinergic receptor-mediated signaling in murine T cells. J Biol Chem272: 25881-25889, 1997
28. Himer L, Csóka B, Selmeczy Z, Koscsó B, Pócza T, Pacher P,Németh ZH, Deitch EA, Vizi ES, Cronstein BN, Haskó G: Adenosine A2A receptor activation protects CD4+ T lymphocytes against activation-induced cell death. FASEB J 24: 2631-2640, 2010
29. Brown ST, Reyes EP, Nurse CA: Chronic hypoxia upregulates adenosine 2a receptor expression in chromaffin cells via hypoxia inducible factor-2a: Role in modulating secretion. BiochemBiophys ResCommun 412: 466-472, 2011
30. Lappas CM, Rieger JM, Linden J: A2A adenosine receptor induction inhibits IFN-gamma production in murine CD4+ T cells. J Immunol 174: 1073-1080, 2005
31. Facchinetti F, Furegato S, Terrazzino S, Leon A: H(2)O(2) induces upregulation of Fas and Fas ligand expression in NGFdifferentiated PC12 cells: Modulation by cAMP. J Neurosci Res 69: 178-188, 2002
32. Ohta A, Sitkovsky M: Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 414: 916-920, 2001
33. Lukashev D, Ohta A, Apasov S, Chen JF, Sitkovsky M: Cutting edge: Physiologic attenuation of proinflammatory transcription by the Gs protein-coupled A2A adenosine receptor in vivo. J Immunol 173: 21-24, 2004
34. Haskó G, Pacher P: A2A receptors in inflammation and injury: Lessons learned from transgenic animals. J Leukoc Biol 83: 447-455, 2008
35. Bauerle JD, Grenz A, Kim JH, Lee HT, Eltzschig HK: Adenosine generation and signaling during acute kidney injury. J Am Soc Nephrol 22: 14-20, 2011
36. Levens N, Beil M, Jarvis M: Renal actions of a new adenosine agonist, CGS 21680A selective for the A2 receptor. J Pharmacol Exp Ther 257: 1005-1012, 1991
37. Day YJ, Huang L,McDuffieMJ, Rosin DL, Ye H, Chen JF, Schwarzschild MA, Fink JS, Linden J, Okusa MD: Renal protection from ischemia mediated by A2A adenosine receptors on bone marrow-derived cells. J Clin Invest 112: 883-891, 2003
38. Kong T, Westerman KA, Faigle M, Eltzschig HK, Colgan SP: HIFdependent induction of adenosine A2B receptor in hypoxia. FASEB J 20: 2242-2250, 2006
39. Synnestvedt K, Furuta GT, Comerford KM, Louis N, Karhausen J, Eltzschig HK, Hansen KR, Thompson LF, Colgan SP: Ecto-59-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia. J Clin Invest 110: 993-1002, 2002
40. Ahmad A, Ahmad S, Glover L, Miller SM, Shannon JM, Guo X, Franklin WA, Bridges JP, Schaack JB, Colgan SP, White CW: Adenosine A2A receptor is a unique angiogenic target of HIF-2alpha in pulmonary endothelial cells. Proc Natl Acad Sci U S A 106: 10684-10689, 2009
41. Sitkovsky M, Ohta A: Targeting the hypoxia-adenosinergic signaling pathway to improve the adoptive immunotherapy of cancer.JMolMed (Berl) 91: 147-155, 2013
42. Sitkovsky MV, Kjaergaard J, Lukashev D, Ohta A: Hypoxiaadenosinergic immunosuppression: Tumor protection by T regulatory cells and cancerous tissue hypoxia. Clin Cancer Res 14: 5947-5952, 2008
43. Holmquist-Mengelbier L, Fredlund E, Löfstedt T,Noguera R,Navarro S, Nilsson H, Pietras A, Vallon-Christersson J, Borg A,Gradin K, Poellinger L, Påhlman S: Recruitment of HIF-1alpha and HIF-2alpha to common target genes is differentially regulated in neuroblastoma: HIF-2alpha promotes an aggressive phenotype. Cancer Cell 10: 413-423, 2006
44. Atkuri KR, Herzenberg LA, Herzenberg LA: Culturing at atmospheric oxygen levels impacts lymphocyte function. Proc Natl Acad Sci U S A 102: 3756-3759, 2005
45. Uldrich AP, Patel O, Cameron G, Pellicci DG, Day EB, Sullivan LC, Kyparissoudis K, Kjer-Nielsen L, Vivian JP, Cao B, Brooks AG, Williams SJ, Illarionov P, Besra GS, Turner SJ, Porcelli SA, McCluskey J, Smyth MJ, Rossjohn J, Godfrey DI: A semi-invariant Va10+ T cell antigen receptor defines a population of natural killer T cells with distinct glycolipid antigen-recognition properties. Nat Immunol 12: 616-623, 2011
46. Mattner J, Debord KL, Ismail N, Goff RD, Cantu C 3rd, Zhou D, Saint-Mezard P, Wang V, Gao Y, Yin N, Hoebe K, Schneewind O, Walker D, Beutler B, Teyton L, Savage PB, Bendelac A: Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434: 525-529, 2005
47. Kinjo Y, Illarionov P, Vela JL, Pei B, Girardi E, Li X, Li Y, Imamura M, Kaneko Y, Okawara A,Miyazaki Y, Gómez-Velasco A, Rogers P, Dahesh S, Uchiyama S, Khurana A, Kawahara K, Yesilkaya H, Andrew PW, Wong CH, Kawakami K, Nizet V, Besra GS, Tsuji M, Zajonc DM, Kronenberg M: Invariant natural killer T cells recognize glycolipids from pathogenic Gram-positive bacteria. Nat Immunol 12: 966-974, 2011
48. Kinjo Y, Tupin E,Wu D, Fujio M, Garcia-Navarro R, Benhnia MR, Zajonc DM, Ben-Menachem G, Ainge GD, Painter GF, Khurana A, Hoebe K, Behar SM, Beutler B, Wilson IA, Tsuji M, Sellati TJ, Wong CH, Kronenberg M: Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nat Immunol 7: 978-986, 2006
49. Kinjo Y,Wu D, KimG, XingGW, PolesMA, HoDD, TsujiM, Kawahara K, Wong CH, Kronenberg M: Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 434: 520-525, 2005
50. Brennan PJ, Tatituri RV, Brigl M, Kim EY, Tuli A, Sanderson JP, Gadola SD, Hsu FF, Besra GS, Brenner MB: Invariant natural killer T cells recognize lipid self antigen induced by microbial danger signals. Nat Immunol 12: 1202-1211, 2011
51. McNab FW, Berzins SP, PellicciDG, Kyparissoudis K, Field K, SmythMJ, GodfreyDI: The influence ofCD1d in postselectionNKT cellmaturation and homeostasis. J Immunol 175: 3762-3768, 2005
52. Matsuda JL, Gapin L, Sidobre S, Kieper WC, Tan JT, Ceredig R, Surh CD, KronenbergM:Homeostasis of V alpha 14iNKT cells. Nat Immunol 3: 966-974, 2002
53. Tupin E, Kronenberg M: Activation of natural killer T cells by glycolipids. Methods Enzymol 417: 185-201, 2006
54. Huang S, Apasov S, Koshiba M, Sitkovsky M: Role of A2a extracellular adenosine receptor-mediated signaling in adenosine-mediated inhibition of T-cell activation and expansion. Blood 90: 1600-1610, 1997